| Product Name | MF | CAS | Details |
|---|
| Hydroxy-PP-Me | C16 H18 N4 O | 833481-77-9 | Details |
| H4R antagonist 2 | C13H17N5O | 1148115-99-4 | Details |
| Du011 | C20H15F2NO4S | 890818-51-6 | Details |
| TIE-2/VEGFR-2 kinase-IN-4 | 433224-29-4 | Details |
| RSV L-protein-IN-4 | C32H35N5O6 | 851657-60-8 | Details |
| Remternetug | 2571940-41-3 | Details |
| Metabutoxycaine | C17H28N2O3 | 3624-87-1 | Details |
| URAT1 inhibitor 5 | C18H14BrN3O2S | 2102670-94-8 | Details |
| Topoisomerase inhibitor 2 | 2713986-17-3 | Details |
| GSK3839919A | C36H46ClN3O3 | 2081127-77-5 | Details |
| WRN inhibitor 2 | 2923009-56-5 | Details |
| Raf inhibitor 3 | 1662682-11-2 | Details |
| KRAS G12C inhibitor 58 | 2915599-52-7 | Details |
| HSP70/SIRT2-IN-2 | 1796557-72-6 | Details |
| α-Pyridoin | C12H12N2O2 | 1141-05-5 | Details |
| Antibacterial agent 157 | 2573134-85-5 | Details |
| KRAS G12C inhibitor 59 | 2914919-88-1 | Details |
| WRN inhibitor 5 | 2923009-95-2 | Details |
| 3β-Hydroxy-lup-20(29)-en-16-one | C30H48O2 | 65043-60-9 | Details |
| Fenquinotrione | C22 H17 Cl N2 O5 | 1342891-70-6 | Details |
| MC-EVCit-PAB-MMAE | 2873452-49-2 | Details |
| Antibacterial agent 135 | C11H15N5O6S | 2233569-54-3 | Details |
| Antiviral agent 35 | 2760972-52-7 | Details |
| TIE-2/VEGFR-2 kinase-IN-3 | 433224-09-0 | Details |
| Tubulin polymerization-IN-56 | 2966790-98-5 | Details |
| VRT-534 | C25H24ClN3O4S | 926664-32-6 | Details |
| DGKα-IN-3 | 2648418-86-2 | Details |
| MS934 | 2756323-15-4 | Details |
| Sirt1/2-IN-3 | C17H14ClNO4S | 301313-42-8 | Details |
| RCB16007 | 2952530-26-4 | Details |
| NOX2-IN-1 | 2648709-25-3 | Details |
| Piperidione | C9H15NO2 | 77-03-2 | Details |
| PLK1/p38γ-IN-1 | 2418614-81-8 | Details |
| S-Pantoprazole sodium trihydrate | C16H15F2N3O4S.3H2O.Na | 1416988-58-3 | Details |
| WRN inhibitor 4 | 2923009-45-2 | Details |
| WRN inhibitor 3 | 2923009-48-5 | Details |
| Usnoflast | C21H29N3O3S | 2455519-86-3 | Details |
| CARM1-IN-3 | C24H32N4O2 | 912970-67-3 | Details |
| NSC309401 | C17H16N6 | 750522-61-3 | Details |
| DGKα-IN-2 | 2648556-92-5 | Details |
| GPR88-IN-1 | 714265-50-6 | Details |
| DDR1/2 inhibitor-2 | 2908756-11-4 | Details |
| ASN90 | C17H21N5O3S | 1884154-02-2 | Details |
| CBP-IN-1 | C27H33F2N7O | 1936431-44-5 | Details |
| Cav 3.2 inhibitor 4 | C21H32Cl2N4O3 | 1416984-93-4 | Details |
| WRN inhibitor 1 | 2923008-44-8 | Details |
| JGK-068S | C22H23BrFN5O2 | 2490431-16-6 | Details |
| Amoxicillin-clavulanate potassium | C24H29KN4O10S | 74469-00-4 | Details |
| Firazorexton hydrate | 2861934-86-1 | Details |
| LFS-1107 | 1799330-91-8 | Details |
| Dobutamine tartrate | C22H29NO9 | 101626-66-8 | Details |
| ZH8667 | C14H14FN | 910387-04-1 | Details |
| DGKα-IN-8 | 2886717-70-8 | Details |
| Pentabromopseudilin | C10H4Br5NO | 10245-81-5 | Details |
| BEBT-109 | C27H32N8O3 | 2050906-40-4 | Details |
| Glycine, N-[(1,1-dimethylethoxy)carbonyl]thio-L-phenylalanyl-, methyl ester | C17H24N2O5S | 128421-85-2 | Details |
| DGKα-IN-4 | 2648723-43-5 | Details |
| NSC 48160 | C18 H29 N O | 6640-90-0 | Details |
| URAT1 inhibitor 6 | 2244807-49-4 | Details |
| Murabutide | C23H40N4O11 | 74817-61-1 | Details |
| TMDJ-035 | 2681302-83-8 | Details |
| Pim-1 kinase inhibitor 5 | 2928606-67-9 | Details |
| PD-L1-IN-3 | C19H15FN2OS.Cl | 2953044-29-4 | Details |
| NLRP3 agonist 1 | 2454019-69-1 | Details |
| GPAT-IN-1 | C21H26ClNO4S | 1204347-51-2 | Details |
| Glycolate oxidase-IN-1 | C12H8O5 | 330977-65-6 | Details |
| STAT6-IN-2 | C28H31N5O2 | 1355594-85-2 | Details |
| Anti-MRSA agent 8 | C20H30O5 | 3118-36-3 | Details |
| Ibuzatrelvir | C21H30F3N5O5 | 2755812-39-4 | Details |
| ALPK1-IN-3 | 2765633-73-4 | Details |
| h15-LOX-2 inhibitor 1 | C17H13F3N2S | 478040-08-3 | Details |
| Duvakitug | 2750005-84-4 | Details |
| HD-2a | 606148-05-4 | Details |
| SARS-CoV-2-IN-44 | 1311271-71-2 | Details |
| αvβ6 integrin inhibitor 2 | C21H30N4O3 | 313709-47-6 | Details |
| Tirfipiravir | C14H17N3O8 | 2759996-93-3 | Details |
| SORT-PGRN interaction inhibitor 2 | C19H31NO | 1008233-79-1 | Details |
| Pterostilbene-isothiocyanate | 1616974-29-8 | Details |
| Antileishmanial agent-23 | C20H17N3O4S2 | 745033-86-7 | Details |
| 4-Thiouridine 5′-triphosphate tetralithium | C9H15N2O14P3S.4Li | 20188-72-1 | Details |
| 2-PCCA hydrochloride | C30H38ClN3O | 1609563-70-3 | Details |
| FEN1-IN-7 | C16H14N2O6S | 824983-90-6 | Details |
| Immune cell migration-IN-2 | C26H22Cl2NO7PS | 2260679-24-9 | Details |
| Trabikibart | 2643974-98-3 | Details |
| DGKζ-IN-4 | 2778366-77-9 | Details |
| BVFP | C13H8BrF3N2O | 357158-20-4 | Details |
| MAO-B-IN-27 | C16H16F3NO.ClH | 788824-83-9 | Details |
| PIM-IN-2 | C19H22N4O2 | 1006699-45-1 | Details |
| JBI-589 | C29H28FN5O | 2308504-22-3 | Details |
| β-Catenin modulator-1 | C21H28N2O4S | 1053086-89-7 | Details |
| TH-Z827 | 2847881-81-4 | Details |
| NSC309401 dihydrochloride | C17H17ClN6 | 77681-42-6 | Details |
| cGAS-IN-1 | C18H19NO8 | 858770-07-7 | Details |
| Riboxin | C10H14N4O11P2 | 86-04-4 | Details |
| PTC258 | C16H18ClN3S2 | 2476724-74-8 | Details |
| Keap1-Nrf2-IN-10 | C25H22I2N4O7S2 | 2445349-54-0 | Details |
| HAPSBC | C15H15N3S2 | 1376545-81-1 | Details |
| NCP2 Anchor | C38H36N4O8 | 1380600-13-4 | Details |
| Rocbrutinib | 2485861-07-0 | Details |
| Tripeptide-32 | C12H22N4O5 | 1185583-20-3 | Details |
| Product Total： Product Page： | ||||
| 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||